Evidence map›Paper›PMID 38383520›Full record

ArticleScientific reports2024

A precise model for skin cancer diagnosis using hybrid U-Net and improved MobileNet-V3 with hyperparameters optimization.

Umesh Kumar Lilhore, Sarita Simaiya, Yogesh Kumar Sharma, Kuldeep Singh Kaswan, K B V Brahma Rao, V V R Maheswara Rao, Anupam Baliyan, Anchit Bijalwan, Roobaea Alroobaea

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Umesh Kumar LilhoreDepartment of Computer Science and Engineering, Chandigarh University, Mohali, Punjab, 140413, India.
Sarita SimaiyaDepartment of Computer Science and Engineering, Chandigarh University, Mohali, Punjab, 140413, India.
Yogesh Kumar SharmaDepartment of Computer Science and Engineering, Koneru Lakshmaiah Education Foundation, Greenfield, Vaddeswaram, Guntur, AP, India.
Kuldeep Singh KaswanSchool of Computing Science and Engineering, Galgotias University, Greater Noida, Uttar Pradesh, India.
K B V Brahma RaoDepartment of Computer Science and Engineering, Koneru Lakshmaiah Education Foundation, Greenfield, Vaddeswaram, Guntur, AP, India.
V V R Maheswara RaoDepartmentt of Computer Science and Engineering, Shri Vishnu Engineering College for Women (A), Bhimavaram, India.
Anupam BaliyanDepartment of Computer Science and Engineering, Chandigarh University, Mohali, Punjab, 140413, India.
Anchit BijalwanArba Minch University, Arba Minch, Ethiopia. drkumarcse@gmail.com.
Roobaea AlroobaeaDepartment of Computer Science, College of Computers and Information Technology, Taif University, P. O. Box 11099, 21944, Taif, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skin cancer is a frequently occurring and possibly deadly disease that necessitates prompt and precise diagnosis in order to ensure efficacious treatment. This paper introduces an innovative approach for accurately identifying skin cancer by utilizing Convolution Neural Network architecture and optimizing hyperparameters. The proposed approach aims to increase the precision and efficacy of skin cancer recognition and consequently enhance patients' experiences. This investigation aims to tackle various significant challenges in skin cancer recognition, encompassing feature extraction, model architecture design, and optimizing hyperparameters. The proposed model utilizes advanced deep-learning methodologies to extract complex features and patterns from skin cancer images. We enhance the learning procedure of deep learning by integrating Standard U-Net and Improved MobileNet-V3 with optimization techniques, allowing the model to differentiate malignant and benign skin cancers. Also substituted the crossed-entropy loss function of the Mobilenet-v3 mathematical framework with a bias loss function to enhance the accuracy. The model's squeeze and excitation component was replaced with the practical channel attention component to achieve parameter reduction. Integrating cross-layer connections among Mobile modules has been proposed to leverage synthetic features effectively. The dilated convolutions were incorporated into the model to enhance the receptive field. The optimization of hyperparameters is of utmost importance in improving the efficiency of deep learning models. To fine-tune the model's hyperparameter, we employ sophisticated optimization methods such as the Bayesian optimization method using pre-trained CNN architecture MobileNet-V3. The proposed model is compared with existing models, i.e., MobileNet, VGG-16, MobileNet-V2, Resnet-152v2 and VGG-19 on the "HAM-10000 Melanoma Skin Cancer dataset". The empirical findings illustrate that the proposed optimized hybrid MobileNet-V3 model outperforms existing skin cancer detection and segmentation techniques based on high precision of 97.84%, sensitivity of 96.35%, accuracy of 98.86% and specificity of 97.32%. The enhanced performance of this research resulted in timelier and more precise diagnoses, potentially contributing to life-saving outcomes and mitigating healthcare expenditures.

Indexed as

Accidental InjuriesMelanomaSkin NeoplasmsBayes TheoremHumansSkinConvolution Neural NetworkDeep learningHealth careSkin cancerTransfer learningU-Net

Identifiers

PMID38383520
PMCPMC10881962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.